The software also detected the ‘sequence effect’ in both iRBD and Parkinson’s patients—a progressive decline in movement speed and amplitude during repetitive actions. This effect could serve as an ...
Medtronic (NYSE: MDT) today announced study results backing its adaptive DBS algorithm for personalized therapy in ...
Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy for Parkinson’s disease.
Neurodegenerative diseases—such as Alzheimer’s, Parkinson’s, Huntington’s, and ALS—are progressive disorders characterized by the loss of structure and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback